Digital Biomarkers Market Trends

Growth Drivers

• Remote Sensing Technologies are Getting More Popular – These technological devices also enable professionals to find patients and retrieve their medical records more rapidly. Remote sensing and monitoring technologies allow healthcare providers to obtain timely information about a patient's vital signs without needing to schedule an in-person visit.
• Growing Use of Biomarkers for Identifying Neurological Disorder– The number of deaths from neurological illnesses has grown by 39% since 1990.  The growing environmental and life pressure has increased the frequency of neurological disorders, such as Alzheimer's disease, dementia, and others. Moreover, healthcare providers and the government are taking initiative to address the problem. Alzheimer's Disease Biomarkers Summit is a digital forum dedicated to addressing the issue of establishing clinically proven markers for early identification and Alzheimer's treatment.
• Rising Development of Drug Delivery Method– AstraZeneca is working to develop new modalities for drug delivery systems to target and control the release of molecules directly into the tissues and cells. Biomarkers enable to increase in the extent of the new drug to reach the desired target.

Challenges

• Standards for Interoperability of Digital Biomarkers are Lacking- Healthcare systems in nations with a low income face intrinsic limitations in addressing seamless connectivity, offering substantial obstacles for healthcare interoperability. Furthermore, the majority of healthcare systems in those locations lack the necessary data insights as well as integration technologies, which is expected to impede product adoption.
• • Biomarker-related security risks
• Long-duration timeline for the development of biomarkers